284 related articles for article (PubMed ID: 34261691)
1. Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.
Wilmot EG; Evans M; Barnard-Kelly K; Burns M; Cranston I; Elliott RA; Gkountouras G; Kanumilli N; Krishan A; Kotonya C; Lumley S; Narendran P; Neupane S; Rayman G; Sutton C; Taxiarchi VP; Thabit H; Leelarathna L
BMJ Open; 2021 Jul; 11(7):e050713. PubMed ID: 34261691
[TBL] [Abstract][Full Text] [Related]
2. Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocol.
Boucher SE; Gray AR; de Bock M; Wiltshire EJ; Galland BC; Tomlinson PA; Rayns J; MacKenzie KE; Wheeler BJ
BMC Endocr Disord; 2019 May; 19(1):50. PubMed ID: 31109342
[TBL] [Abstract][Full Text] [Related]
3. Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial.
Zhou Y; Deng H; Liu H; Yang D; Xu W; Yao B; Yan J; Weng J
BMJ Open; 2020 Dec; 10(12):e039400. PubMed ID: 33277281
[TBL] [Abstract][Full Text] [Related]
4. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
[TBL] [Abstract][Full Text] [Related]
5. Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol.
Fuchs J; Allen JM; Boughton CK; Wilinska ME; Thankamony A; de Beaufort C; Campbell F; Yong J; Froehlich-Reiterer E; Mader JK; Hofer SE; Kapellen TM; Rami-Merhar B; Tauschmann M; Hood K; Kimbell B; Lawton J; Roze S; Sibayan J; Cohen N; Hovorka R;
BMJ Open; 2021 Feb; 11(2):e042790. PubMed ID: 33579766
[TBL] [Abstract][Full Text] [Related]
6. Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial - study protocol.
Beunen K; Van Wilder N; Ballaux D; Vanhaverbeke G; Taes Y; Aers XP; Nobels F; Marlier J; Lee D; Cuypers J; Preumont V; Siegelaar SE; Painter RC; Laenen A; Gillard P; Mathieu C; Benhalima K
BMC Pregnancy Childbirth; 2023 Mar; 23(1):180. PubMed ID: 36927458
[TBL] [Abstract][Full Text] [Related]
7. Study protocol for optimising glycaemic control in type 1 diabetes treated with multiple daily insulin injections: intermittently scanned continuous glucose monitoring, carbohydrate counting with automated bolus calculation, or both? A randomised controlled trial.
Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal TP; Dørflinger L; Vistisen D; Nørgaard K
BMJ Open; 2020 Apr; 10(4):e036474. PubMed ID: 32345699
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction.
Everett CC; Reynolds C; Fernandez C; Stocken DD; Sharples LD; Sathyapalan T; Heller S; Storey RF; Ajjan RA
Diab Vasc Dis Res; 2020; 17(5):1479164120957934. PubMed ID: 33081502
[TBL] [Abstract][Full Text] [Related]
9. Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol.
Musolino G; Allen JM; Hartnell S; Wilinska ME; Tauschmann M; Boughton C; Campbell F; Denvir L; Trevelyan N; Wadwa P; DiMeglio L; Buckingham BA; Weinzimer S; Acerini CL; Hood K; Fox S; Kollman C; Sibayan J; Borgman S; Cheng P; Hovorka R
BMJ Open; 2019 Jun; 9(6):e027856. PubMed ID: 31164368
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Patient-reported Satisfaction and Metabolic Outcomes Following Initiation of the Second Generation of Flash Glucose Monitoring in Patients with Type 1 Diabetes.
Al Hayek A; Robert AA; Alzahrani WM; Al Dawish MA
Curr Diabetes Rev; 2024; 20(4):e100823219628. PubMed ID: 37563819
[TBL] [Abstract][Full Text] [Related]
11. A comparison of FreeStyle Libre 2 to self-monitoring of blood glucose in children with type 1 diabetes and sub-optimal glycaemic control: a 12-week randomised controlled trial protocol.
Styles S; Wheeler B; Boucsein A; Crocket H; de Lange M; Signal D; Wiltshire E; Cunningham V; Lala A; Cutfield W; de Bock M; Serlachius A; Jefferies C
J Diabetes Metab Disord; 2021 Dec; 20(2):2093-2101. PubMed ID: 34900845
[TBL] [Abstract][Full Text] [Related]
12. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
[TBL] [Abstract][Full Text] [Related]
13. Implementation research: a protocol for two three-arm pragmatic randomised controlled trials on continuous glucose monitoring devices in people with type 1 diabetes in South Africa and Kenya.
Marbán-Castro E; Muhwava L; Kamau Y; Safary E; Rheeder P; Karsas M; Kemp T; Freitas J; Carrihill M; Dave J; Katambo D; Kimetto J; Allie R; ; ; Ndungu J; Sigwebela N; Akach D; Girdwood S; Erkosar B; Nichols BE; Haldane C; Vetter B; Shilton S
Trials; 2024 May; 25(1):331. PubMed ID: 38773658
[TBL] [Abstract][Full Text] [Related]
14. Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes.
Scott EM; Bilous RW; Kautzky-Willer A
Diabetes Technol Ther; 2018 Mar; 20(3):180-188. PubMed ID: 29470094
[TBL] [Abstract][Full Text] [Related]
15. Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled Trial.
Jefferies CA; Boucsein A; Styles SE; Chamberlain B; Michaels VR; Crockett HR; De Lange M; Lala A; Cunningham V; Wiltshire EJ; Serlachius AS; Wheeler BJ
Diabetes Technol Ther; 2023 Dec; 25(12):827-835. PubMed ID: 37782139
[No Abstract] [Full Text] [Related]
16. Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.
Parsons S; Luzio S; Bain S; Harvey J; McKenna J; Khan A; Rice S; Watkins A; Owens DR
BMC Endocr Disord; 2017 Jan; 17(1):4. PubMed ID: 28143495
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of the freestyle libre 2 flash glucose monitoring system on diabetes-self-management practices and glycemic parameters among patients with type 1 diabetes using insulin pump.
Al Hayek AA; Robert AA; Al Dawish MA
Diabetes Metab Syndr; 2021; 15(5):102265. PubMed ID: 34488057
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of real-time continuous glucose monitoring to improve glycaemic control and pregnancy outcome in patients with gestational diabetes mellitus: a study protocol for a randomised controlled trial.
Huhn EA; Linder T; Eppel D; Weißhaupt K; Klapp C; Schellong K; Henrich W; Yerlikaya-Schatten G; Rosicky I; Husslein P; Chalubinski K; Mittlböck M; Rust P; Hoesli I; Winzeler B; Jendle J; Fehm T; Icks A; Vomhof M; Greiner GG; Szendrödi J; Roden M; Tura A; Göbl CS
BMJ Open; 2020 Nov; 10(11):e040498. PubMed ID: 33257486
[TBL] [Abstract][Full Text] [Related]
19. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.
Malanda UL; Welschen LM; Riphagen II; Dekker JM; Nijpels G; Bot SD
Cochrane Database Syst Rev; 2012 Jan; 1():CD005060. PubMed ID: 22258959
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
